Seres Therapeutics Reports Third Quarter Earnings Miss on Revenue and EPS
Seres Therapeutics (MCRB) reported third-quarter financial results that fell significantly short of market expectations. The company posted a GAAP earnings per share (EPS) of -$1.63, missing estimates by $0.63. While revenue grew 68.6% year-over-year to reach $0.59 million, this figure missed consensus estimates by $5.76 million. Following the announcement, shares experienced a sharp decline of approximately 11% in after-hours trading.
Topics: EPS miss quarterly earnings revenue miss stock price movement
Read the full article at Seeking Alpha
Part of the story Alphabet Reports Third Quarter Earnings Miss Amid High AI Capital Expenditures (6 articles)